Cuiling Li

Dr. Cuiling Li

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
FXFei Xiao
Fei Xiao
RFRui Fan
Rui Fan
JZJingwei Zhang
Jingwei Zhang
MYMin Ye
Min Ye
WLWei Li
Wei Li
CLCuiling Li
Cuiling Li
The study was mainly to evaluate the changes of left ventricular (LV) myocardial work (MW) in children with CKD stage 5 within 3 months after kidney transplantation (KTx). Forty‐three successful KTx recipients (mean age 10.6 years, 58% male) in childhood and 28 healthy children were enrolled. General clinical characteristics and laboratory parameters were collected. Cardiac structure, function, and LV MW were assessed by echocardiography before and after KTx. The results showed that significantly improvement was observed in LV global MW index (GWI), constructive MW (GCW), and wasted MW (GWW) (p < .01), but not in MW efficiency (GWE) and global longitudinal strain (GLS) (p > .05). Besides, blood pressure (BP), renal graft function, LV ejection fraction (LVEF), and LV mass index (LVMi) had obviously improved after KTx (p < .05). Nevertheless, compared with healthy children, higher BP, LVMi, GWW, more deteriorated LV diastolic function and lower GWE were still observed in patients after KTx. The ratio of dialysis duration to CKD course were negatively correlated with the improvements of GWE (p = .004), GWI (p = .01), and GCW (p = .01). In conclusion, a portion of LV MW parameters were obviously improved in children received KTx. Thus, LV MW was superior to GLS in evaluating LV systolic function recovery in these patients. Those patients with insignificant MW improvement should be closely monitored, and adjusted the treatment strategies timely to avoid serious and irreversible myocardial injury after KTx.


25 October 2019 in Echocardiography
Verified
Journal Article
Closed access
PDF file
CLCuiling Li
Cuiling Li
JZJingwei Zhang
Jingwei Zhang
RFRui Fan
Rui Fan
LCLili Chen
Lili Chen
DLDonghong Liu
Donghong Liu
HLHong Lin
Hong Lin

2 September 2025 in Echocardiography
Verified
Journal Article
Closed access
MWMinjie Wan
Minjie Wan
WLWei Li
Wei Li
FYFengjuan Yao
Fengjuan Yao
DLDonghong Liu
Donghong Liu
CLCuiling Li
Cuiling Li

24 September 2022 in International Journal of Hypertension
Verified
Journal Article
Open access
PDF file
WDWenyue Dai
Wenyue Dai
YLYanqiu Liu
Yanqiu Liu
FYFengjuan Yao
Fengjuan Yao
WLWei Li
Wei Li
JLJia Liu
Jia Liu
DLDonghong Liu
Donghong Liu
Objective. The aim of this study was to investigate the changes of syndecan-4 (SDC-4) during the hypertensive period in two kidney-two clip (2K2C) hypertension rats and compare them to brain natriuretic peptide (BNP) and the echocardiographic parameters for diastolic function evaluation in the rat model of 2K2C hypertension. Methods. A total of 36 Sprague–Dawley (SD) rats were used in this study. Hypertension was induced in 21 by 2K2C surgery, and 15 were sham-operated. Both the 2K2C hypertension group (n = 21) and the sham-operated group (n = 15) were equally divided into 3 subgroups according to the schedules (week 4, week 8, and week 12). Serum SDC-4 and BNP were detected by ELISA, and echocardiography indexes were acquired. Results. The level of SDC-4 and cardiac fibrosis increased gradually as the experiment was processed, and BNP, Tei index, and E/E′ followed to be raised as high blood pressure was maintained after four weeks in the 2K2C hypertension rats. In the earlier 4 weeks, only SDC-4 and cardiac fibrosis were significantly increased in 2K2C hypertensive rats in comparison with normotensive rats. And it was shown that SDC-4 was positively correlated with BNP level during the entire study (r = 0.762, ). Conclusion. SDC-4 increases gradually during the process of diastolic dysfunction in 2K2C hypertensive rats. SDC-4 is the earliest biomarker reflecting diastolic dysfunction in this model, superior to E/E′ and the Tei index. Our results indicate that serum SDC-4 could act as an early biomarker to show diastolic dysfunction.

7 July 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
ZZZiwei Zhou
Ziwei Zhou
CLCuiling Li
Cuiling Li
SZShaozhao Zhang
Shaozhao Zhang
MYMin Ye
Min Ye
XXXinghao Xu
Xinghao Xu
XZXiao-dong Zhuang
Xiao-dong Zhuang
Background: Tricuspid regurgitation (TR) progression correlates with worsened clinical outcomes. The stress hyperglycemia ratio (SHR), a biomarker of acute glycemic dysregulation under stress, has prognostic validity in multiple valvular diseases. This study aims to investigate the correlation between SHR and clinical prognosis in patients with moderate to severe TR. Methods: Leveraging the RED‐CARPET (Real‐World Data of Cardiometabolic Protection) registry from the First Affiliated Hospital of Sun Yat‐sen University, we analyzed 531 patients with moderate‐to‐severe TR categorized into quartiles (quartiles 1–4) by SHR. Primary end points were all‐cause and cardiovascular disease (CVD) death. The association between SHR and death was assessed using a multivariable‐adjusted Cox regression model. The incremental predictive value of incorporating SHR into the traditional risk model was also analyzed. Results: The cohort (mean age, 70.93 years) exhibited 38.9% all‐cause deaths (207 events) and 20.0% CVD deaths (106 events) over 5.9‐year median follow‐up. After full adjustment, patients with SHR quartile 4 carried a 108% excess risk of all‐cause death (hazard ratio [HR], 2.08 [95% CI, 1.34–3.23]) and more than twice the hazard of CVD death (HR, 2.40 [95% CI, 1.30–4.43]) versus quartile 1. The addition of SHR into the basic risk model for all‐cause and CVD death improved the concordance statistics (both P <0.001), continuous‐free net reclassification improvement value ( P =0.040 for all‐cause death and P =0.046 for CVD death), and integrated discrimination improvement value ( P =0.040 for both all‐cause and CVD death). Conclusions: Elevated SHR is associated with an increased risk of all‐cause death and CVD death in patients with moderate to severe TR.